肌萎缩侧索硬化患者一级和二级亲属神经精神疾病的聚集性研究
这项基于爱尔兰ALS登记处的病例对照家族聚集性研究纳入127例ALS患者和132名年龄性别匹配的对照,评估其一级和二级亲属中神经精神疾病的患病率。结果显示ALS亲属中精神分裂症、精神病、自杀、抑郁、酗酒或自闭症病史的风险显著高于对照(RR 1.50)。C9orf72重复扩增不能完全解释该关联,提示存在其他多效性基因。
要点
- ALS患者亲属中精神分裂症、自杀、自闭症和酗酒风险显著升高。
- C9orf72重复扩增仅见于17.2%有强神经精神家族史的先证者。
- 应关注ALS家系中神经精神疾病的聚集现象。
核心结论
- ALS亲属中神经精神疾病(包括强迫症、自闭症和酗酒)比对照更常见。
- C9orf72重复扩增不能完全解释该发现,提示存在其他多效性基因。
研究设计与样本
- 基于人群的病例对照家族聚集性研究,纳入爱尔兰ALS登记处2012年1月1日至2014年1月31日期间的127例散发ALS患者和132名年龄性别匹配的对照。
- 对患者进行C9orf72重复扩增基因分型,并收集一级和二级亲属的神经精神疾病史。
主要发现
- 29例有强神经精神疾病家族史(≥3名一级或二级亲属)的先证者中,5例(17.2%)携带C9orf72重复扩增。
临床怎么用
- 在ALS患者临床评估中,应询问家族中神经精神疾病史,包括精神分裂症、自杀、自闭症和酗酒。
- 对于有强神经精神疾病家族史的ALS家系,可考虑遗传咨询和进一步基因检测。
局限性
- 研究基于爱尔兰人群,结果外推需谨慎。
- 家族史信息依赖患者或对照报告,可能存在回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the motor system. There is increasing epidemiologic evidence of an association between ALS and a wider spectrum of neurodegenerative and neuropsychiatric disorders among family members, including schizophrenia and psychotic illness and suicidal behavior. OBJECTIVE: To examine the frequency and range of neuropsychiatric conditions that occur within individual first-degree and second-degree relatives of patients with ALS. DESIGN, SETTING, AND PARTICIPANTS: In this population-based, case-control family aggregation study, all 202 patients included in the Irish ALS Register between January 1, 2012, and January 31, 2014, with definite, probable, or possible ALS as defined by El Escorial criteria were invited to participate. A total of 75 patients were unable or refused to participate and were excluded; the remaining 127 patients with incident ALS were genotyped for the C9orf72 repeat expansion and 132 age- and sex-matched controls were included in the study. MAIN OUTCOME AND MEASURES: The prevalence of defined neuropsychiatric disease in first-degree and second-degree relatives of patients with ALS and matched controls was determined. RESULTS: Mean (SD) age at diagnosis of the 127 patients in the study (58 women and 69 men) was 64.2 (10.7) years. Data from 2116 relatives of patients with ALS were reported, including 924 first-degree relatives, 1128 second-degree relatives, and 64 third-degree relatives. Data from controls were reported from 829 first-degree and 1310 second-degree relatives. A total of 77 patients with ALS (61.4%) and 51 control participants (38.6%) reported at least 1 first-degree or second-degree relative with a history of schizophrenia, psychosis, suicide, depression, alcoholism, or autism (relative risk [RR], 1.50; 95% CI, 1.08-2.17; P = .02). Cluster analysis suggested the following 2 subgroups based on the number of family members with a neuropsychiatric condition: expected (0-2) and high (≥3). Within the high subgroup, ALS kindreds presented a significantly higher rate of psychiatric illness than did controls (28 of 39 [71.8%]; mean [SD] number of siblings, 4.29 [1.41]; P = .001). A strong family history of schizophrenia (RR, 3.40; 95% CI, 1.27-9.30; P = .02), suicide (RR, 3.30; 95% CI, 1.07-10.05; P = .04), autism (RR, 10.10; 95% CI, 1.30-78.80; P = .03), and alcoholism (RR, 1.48; 95% CI, 1.01-2.17; P = .045) was reported in ALS kindreds. A total of 5 of 29 probands (17.2%) with a strong family history of neuropsychiatric conditions (≥3 first-degree or second-degree relatives) carried the C9orf72 repeat expansion. CONCLUSIONS AND RELEVANCE: Neuropsychiatric symptoms in addition to schizophrenia, including obsessive-compulsive disorder, autism, and alcoholism, occur more frequently in ALS kindreds than in controls. The presence of the C9orf72 repeat expansion does not fully account for this finding, suggesting the presence of additional pleiotropic genes associated with both ALS and neuropsychiatric disease in the Irish population.
引用
- O'Brien M, Burke T, Heverin M, et al. Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2017. PMID: 29049464. doi:10.1001/jamaneurol.2017.2699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。